GO
Loading...

Medicine

More

  • Correction: Bird Flu story Friday, 17 Apr 2015 | 6:24 PM ET

    ST. PAUL, Minn.— In a story April 16 about bird flu, The Associated Press reported erroneously that recent outbreaks had led to the death of more than 2.5 million turkeys and chickens. USDA veterinarian: Bird flu outbreak could be' devastating'. Top USDA veterinarian: Bird flu outbreak may last for years and be' devastating' to poultry.

  • April 17- Pfizer Inc was cleared of liability on Friday in the first lawsuit to go to trial of more than 1,000 filed across the United States alleging that its antidepressant Zoloft can cause birth defects, a company spokeswoman said. Plaintiff Kristyn Pesante claimed that Pfizer failed to warn that using Zoloft during pregnancy could cause birth defects, and...

  • No. 1 egg-producing state aims to keep bird flu out Friday, 17 Apr 2015 | 5:22 PM ET

    DES MOINES, Iowa— The discovery of bird flu on an Iowa turkey farm has raised serious concerns that the poultry-killing virus could find its way into chicken barns in the nation's top egg-producing state and rapidly decimate flocks that provide the U.S. with its breakfast staple. Iowa is home to roughly 50 million hens that lay nearly one in every five eggs...

  • April 17- A large study of Bristol-Myers Squibb Co's Opdivo treatment has been halted after proving the drug is effective against the most common form of lung cancer, the company said, positioning the medicine for far wider use than its already approved lung cancer and melanoma indications. AstraZeneca Plc, Pfizer Inc and other drugmakers are developing their...

  • Glaxo recalls flu vaccine due to potency problem Friday, 17 Apr 2015 | 1:24 PM ET

    WASHINGTON— GlaxoSmithKline is recalling remaining doses of a popular four-in-one flu vaccine because of effectiveness problems. But Glaxo said in a letter it "cannot rule out potential suboptimal protection" in people who received the vaccine in early January or later. More than 99 percent of the vaccines were distributed in 2014, before the product began...

  • LOS ANGELES— California health authorities on Friday declared an end to a large measles outbreak that started at Disneyland and triggered a national debate about vaccinations. Disease detectives for months raced to contain the highly contagious disease, which surfaced at Disney theme parks in December and spread to a half-dozen U.S. states, Mexico and...

  • A promising treatment from Bristol-Myers Squibb may be fast-tracking toward another approved use after researchers stopped a study early because the drug did better than an older treatment in patients with an advanced form of lung cancer. Shares of the New York drugmaker jumped Friday morning after it said Opdivo fared better than the chemotherapy drug...

  • April 17- Drug developer Athersys Inc said its cell therapy failed in a mid-stage study testing it as a treatment for a type of stroke, sending its shares down more than 50 percent in premarket trading. Athersys said on Friday patients given the cell therapy did not show a significant difference from those given a placebo as measured by the Global Stroke Recovery...

  • Clifford spoke on a visit to Minnesota, the state hit hardest by outbreaks that have cost Midwest producers over 2 million turkeys and chickens since early March. He said the fact that the highly pathogenic H5N2 virus has already appeared as far east as southern Ontario means there's an uncomfortable risk of it spreading to the East Coast where much of the U.S....

  • The copied 20 mg version of the blockbuster drug, submitted by Sandoz, a unit of Swiss drugmaker Novartis AG, can be labeled "substitutable" for Copaxone, meaning that prescriptions for the brand-name drug can be automatically switched to the generic. The generic drug, called Glatopa, was developed collaboratively by Novartis and Momenta Pharmaceuticals Inc...

  • Petco reopening 2 Chicago boarding centers Thursday, 16 Apr 2015 | 8:10 AM ET

    NEW YORK— Petco plans to reopen two of its pet boarding and daycare centers in Chicago on a limited scale after shutting down for two weeks as a precaution over a surge in canine flu cases. The two Pooch Hotel locations will open Friday for customers that have legitimate needs, the San Diego- based company said. "We share in our community's concern about protecting...

  • Cancer therapy developer Aduro becomes 2015's biggest IPO Wednesday, 15 Apr 2015 | 7:00 PM ET

    NEW YORK— Move over, Shake Shack: the title of 2015' s biggest IPO now belongs to a company developing a cancer treatment based on the deadly Listeria bacterium. That's a climb of 147 percent, topping Shake Shack's 119- percent jump in January. Shake Shack Inc., known for its burgers, milkshakes and crinkle-cut fries, opened at $21 on Jan. 30 and finished the day at $45.90.

  • April 15- U.S. health regulators on Wednesday approved Amgen Inc's Corlanor to treat patients with chronic heart failure, giving the world's largest biotechnology company its first cardiovascular product. RBC Capital Markets analyst Michael Yee said that long term Corlanor could become a $500 million a year drug for Amgen. Amgen shares rose 1.3 percent in...

  • Bird flu outbreak could head eastward with fall migration Wednesday, 15 Apr 2015 | 5:00 PM ET

    Now they're preparing for the worst, said Donna Carver, extension veterinarian at North Carolina State University. The highly pathogenic H5N2 avian influenza strain has turned up since December in commercial poultry farms, backyard flocks wild birds in the Pacific and Central flyways, but it's done the most damage in the heavily traveled Mississippi Flyway,...

  • FDA approves new type of heart failure drug from Amgen Wednesday, 15 Apr 2015 | 4:53 PM ET

    TRENTON, N.J.— Patients with chronic heart failure, a disabling, deadly disease that worsens as the heart gradually pumps less efficiently, are getting a much-needed new option with U.S. approval Wednesday of a novel drug from Amgen Inc.. Meanwhile, the Food and Drug Administration is reviewing another heart failure pill, from Novartis AG, and could approve it this...

  • Aduro surges on IPO   Wednesday, 15 Apr 2015 | 11:24 AM ET
    Aduro surges on IPO

    Is it the golden age for cancer research Stephen Isaacs, Aduro Biotech CEO, discusses some of the advances in medicine of late.

  • WASHINGTON, April 14- AstraZeneca Plc's diabetes drug Onglyza and Takeda Pharmaceutical Co.' s rival product Nesina should carry information about the risk of heart failure, an advisory committee to the U.S. Food and Drug Administration said on Tuesday. The panel reviewed safety data on AstraZeneca's Onglyza and Takeda's Nesina. The studies were requested by...

  • Curing eye disease, and maybe color blindness   Tuesday, 14 Apr 2015 | 5:43 PM ET
    Curing eye disease, and maybe color blindness

    Avalanche Biotechnologies founder and CEO Thomas Chalberg, discusses treatments for wet macular degeneration, and a potential treatment for color blindness.

  • April 14- An advisory panel to the U.S. Food and Drug Administration voted 13-3 that Takeda Pharmaceutical's diabetes drug Nesina should contain information about a potential increased risk of heart failure. The panel voted 16-0 that the drug has an acceptable overall cardiovascular safety profile, with no significant increased risk of major heart events...

  • DES MOINES, Iowa— A bird-flu strain that has already led to the deaths of nearly 2 million turkeys nationwide spread to an Iowa turkey farm, authorities said on Tuesday, bringing to six the number of states hit with the outbreak that was also confirmed at eight more farms in Minnesota. The Iowa farm is in Buena Vista County housing some 27,000 turkeys, said Iowa...